El año pasado, Phibro Animal Health Corp generó 810.73M USD en su segmento con mejor rendimiento, MFAs and Other. United States realizó la mayor aportación, representando 877.13M USD el año pasado. Para el último trimestre, Phibro Animal Health Corp reportó unos ingresos de 207.63M USD para el periodo finalizado el 2026-06-30, procedentes del segmento con mejor rendimiento, MFAs and Other. United States aportó los mayores ingresos, alcanzando los 220.25M USD.

Por negocio

Ingresos operativos

Proporción

Anual

Anual

Trimestral

MFAs and Other

Nutritional specialties

Vaccines

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

MFAs and Other

810.73M(69.76%)

646.35M(67.13%)

420.96M(59.59%)

387.35M(58.70%)

361.54M(59.56%)

330.02M(60.47%)

322.30M(61.17%)

350.47M(65.88%)

Nutritional specialties

195.07M(16.78%)

179.29M(18.62%)

164.67M(23.31%)

172.50M(26.14%)

157.20M(25.89%)

142.76M(26.16%)

129.26M(24.53%)

113.22M(21.28%)

Vaccines

156.42M(13.46%)

137.15M(14.25%)

120.85M(17.11%)

100.00M(15.15%)

88.32M(14.55%)

72.94M(13.37%)

75.34M(14.30%)

68.29M(12.84%)

Por región

Ingresos operativos

Proporción

Anual

Anual

Trimestral

United States

Europe & Middle East & Africa

Asia Pacific

Latin America and Canada

Israel

FY2026

FY2025

FY2024

FY2023

FY2022

FY2021

FY2020

FY2019

FY2018

FY2017

FY2016

FY2015

FY2014

FY2013

FY2012

United States

877.13M(57.78%)

739.92M(57.08%)

584.76M(57.46%)

578.77M(59.19%)

561.80M(59.62%)

494.89M(59.39%)

471.94M(58.97%)

480.10M(57.98%)

494.60M(60.32%)

484.15M(63.35%)

473.25M(62.97%)

475.94M(63.58%)

435.41M(62.93%)

414.77M(63.50%)

424.37M(64.88%)

Europe & Middle East & Africa

340.67M(22.44%)

160.23M(12.36%)

121.98M(11.99%)

117.81M(12.05%)

122.48M(13.00%)

114.13M(13.70%)

112.18M(14.02%)

105.36M(12.73%)

43.90M(5.35%)

40.21M(5.26%)

36.18M(4.81%)

36.40M(4.86%)

38.56M(5.57%)

32.50M(4.98%)

30.09M(4.60%)

Asia Pacific

187.94M(12.38%)

97.42M(7.52%)

63.23M(6.21%)

61.45M(6.28%)

66.93M(7.10%)

58.01M(6.96%)

57.30M(7.16%)

90.15M(10.89%)

51.41M(6.27%)

50.48M(6.61%)

46.44M(6.18%)

43.22M(5.77%)

43.42M(6.28%)

44.06M(6.75%)

36.93M(5.65%)

Latin America and Canada

112.36M(7.40%)

298.65M(23.04%)

247.71M(24.34%)

219.85M(22.48%)

191.05M(20.28%)

166.32M(19.96%)

158.94M(19.86%)

152.38M(18.40%)

120.85M(14.74%)

96.69M(12.65%)

105.67M(14.06%)

99.58M(13.30%)

84.78M(12.25%)

68.58M(10.50%)

61.41M(9.39%)

Israel

--(--)

109.22M(13.32%)

92.75M(12.14%)

90.00M(11.98%)

93.46M(12.48%)

89.74M(12.97%)

93.25M(14.28%)

101.30M(15.49%)